Cargando…
Efficient Selection of Genetically Modified Human T Cells Using Methotrexate-Resistant Human Dihydrofolate Reductase
Genetic modification of human T cells to express transgene-encoded polypeptides, such as tumor targeting chimeric antigen receptors, is an emerging therapeutic modality showing promise in clinical trials. The development of simple and efficient techniques for purifying transgene(+) T cells is needed...
Autores principales: | Jonnalagadda, Mahesh, Brown, Christine E., Chang, Wen C., Ostberg, Julie R., Forman, Stephen J., Jensen, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028078/ https://www.ncbi.nlm.nih.gov/pubmed/23303282 http://dx.doi.org/10.1038/gt.2012.97 |
Ejemplares similares
-
Engineering Human T Cells for Resistance to Methotrexate and Mycophenolate Mofetil as an In Vivo Cell Selection Strategy
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013) -
In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase
por: Gori, Jennifer L., et al.
Publicado: (2009) -
Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
por: Wang, Yinghui, et al.
Publicado: (2021) -
A comparative molecular docking study of curcumin and methotrexate to dihydrofolate reductase
por: Hobani, Yahya, et al.
Publicado: (2017) -
In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics
por: Rana, Rabia Mukhtar, et al.
Publicado: (2020)